Advanced Biomed Inc. Common Stock (ADVB) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Advanced Biomed Inc. Comm...

    NASDAQ: ADVB · Real-Time Price · USD
    0.47
    -0.04 (-7.44%)
    At close: Jul 31, 2025, 3:59 PM

    Advanced Biomed Common Stock Income Statement

    Financials in USD. Fiscal year is July - June.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2023 FY 2022 FY 2021
    Period Ending Jun 30, 2024 Jun 30, 2023 Jun 30, 2022
    Revenue
    		 n/a n/a n/a
    Cost of Revenue
    		 12.55K 11.89K 4.48K
    Gross Profit
    		 -12.55K -11.89K -4.48K
    Operating Income
    		 -2.54M -3.07M -2.37M
    Interest Income
    		 53.49K 21.4K 243.00
    Pretax Income
    		 -2.78M -3.73M -4.03M
    Net Income
    		 -2.78M -3.73M -4.03M
    Selling & General & Admin
    		 1.26M 1.32M 624.77K
    Research & Development
    		 880.19K 1.38M 1.62M
    Other Expenses
    		 399.6K 365.23K 130.07K
    Operating Expenses
    		 2.54M 3.07M 2.37M
    Interest Expense
    		 n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a
    Cost & Expenses
    		 2.54M 3.07M 2.37M
    Income Tax Expense
    		 n/a n/a n/a
    Shares Outstanding (Basic)
    		 20M 19.93M 14.18M
    Shares Outstanding (Diluted)
    		 20M 19.94M 14.18M
    EPS (Basic)
    		 -0.14 -0.19 -0.28
    EPS (Diluted)
    		 -0.14 -0.19 -0.28
    EBITDA
    		 -2.14M -2.71M -2.24M
    EBIT
    		 -2.54M -3.07M -2.37M
    Depreciation & Amortization
    		 399.6K 365.23K 126.63K

    Add to Watchlist